Literature DB >> 3860289

Cell cycle sensitivity of HL-60 cells to the differentiation-inducing effects of 1-alpha,25-dihydroxyvitamin D3.

G P Studzinski, A K Bhandal, Z S Brelvi.   

Abstract

A recently described system for monocyte-like differentiation of HL-60 cells was utilized to determine if the initiation of this pathway can be linked to a set of replicative cellular events. The standard induction system consisted of a 4-h exposure to 100 nM 1-alpha,25-dihydroxyvitamin D3 [1,25(OH)2D3] followed by determination of nonspecific esterase and phagocytic activity 24 h later. The cell cycle status was ascertained by the incorporation of [3H]thymidine and autoradiography. Studies in which cell cycle block in the G1/S phase boundary region was produced by a partial inhibition of DNA synthesis with thymidine, or sodium butyrate, showed that the exposure of such semisynchronous cultures to 1,25(OH)2D3 resulted in an increased proportion of differentiated cells. Conversely, blocking the cell cycle with vinblastine (G2/M block) or theobromine (mid-G1 block) inhibited the initiation of differentiation by 1,25(OH)2D3. Experiments in which the differentiated cells were examined for the cell cycle position at the time of the exposure to 1,25(OH)2D3 by [3H]thymidine labeling and autoradiography confirmed that the late G1 and early S phase cells are those which predominate in the differentiated fraction of 1,25(OH)2D3-treated HL-60 cultures. These results link pre- and early replicative cellular events to the induction of monocytic differentiation by 1,25(OH)2D3.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3860289

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  1{alpha},25-Dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusion.

Authors:  Michele N Washington; Nancy L Weigel
Journal:  Endocrinology       Date:  2010-02-10       Impact factor: 4.736

2.  1,25-dihydroxyvitamin D3 enhances the apoptotic activity of MDM2 antagonist nutlin-3a in acute myeloid leukemia cells expressing wild-type p53.

Authors:  Thelma Thompson; Michael Andreeff; George P Studzinski; Lyubomir T Vassilev
Journal:  Mol Cancer Ther       Date:  2010-04-20       Impact factor: 6.261

3.  19-nor-1alpha,25-dihydroxyvitamin D(2) (paricalcitol): effects on clonal proliferation, differentiation, and apoptosis in human leukemic cell lines.

Authors:  István Molnár; Timothy Kute; Mark C Willingham; Bayard L Powell; William H Dodge; Gary G Schwartz
Journal:  J Cancer Res Clin Oncol       Date:  2003-02-12       Impact factor: 4.553

4.  1 alpha,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro.

Authors:  C M Hansen; T L Frandsen; N Brünner; L Binderup
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

5.  Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line.

Authors:  M G Thomas; S Tebbutt; R C Williamson
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

6.  MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3.

Authors:  Xuening Wang; Elzbieta Gocek; Chang-Gong Liu; George P Studzinski
Journal:  Cell Cycle       Date:  2009-03-18       Impact factor: 4.534

Review 7.  Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor.

Authors:  Carsten Carlberg; Moray J Campbell
Journal:  Steroids       Date:  2012-11-23       Impact factor: 2.668

8.  Luminal and humoral influences on human rectal epithelial cytokinetics.

Authors:  M G Thomas
Journal:  Ann R Coll Surg Engl       Date:  1995-03       Impact factor: 1.891

9.  Changes in the expression of oncogenes encoding nuclear phosphoproteins but not c-Ha-ras have a relationship to monocytic differentiation of HL 60 cells.

Authors:  Z S Brelvi; G P Studzinski
Journal:  J Cell Biol       Date:  1986-06       Impact factor: 10.539

10.  1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells.

Authors:  JoyAnn N Phillips Rohan; Nancy L Weigel
Journal:  Endocrinology       Date:  2009-01-22       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.